Steris (STE) has disclosed a new risk, in the Debt & Financing category.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
STERIS’s significant debt level, amounting to approximately $2,043.7 million as of March 31, 2025, poses a substantial risk to its financial and business flexibility. The company’s ability to manage this debt is contingent on its financial performance and external market conditions, which are beyond its control. This indebtedness may constrain STERIS’s capacity to secure additional financing, allocate cash flow effectively, and remain competitive against less leveraged peers. Furthermore, fluctuations in credit ratings and interest rates could exacerbate these challenges, potentially impacting operations adversely.
Overall, Wall Street has a Moderate Buy consensus rating on STE stock based on 4 Buys and 3 Holds.
To learn more about Steris’ risk factors, click here.